In the published article, there were errors in affiliations 1–5. Instead of “1 School of Public Health, College of Public Health, Taipei, Taiwan, 2 Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 3 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, 4 Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan, 5 Department of Health Care Administration, Chung-Hwa University of Medical Technology, Tainan, Taiwan” it should be “1 School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan, 2 Department of Critical Care Medicine, Taipei Medical University Hospital, Taipei, Taiwan, 3 Department of Clinical Pathology, Taipei Medical University, Taipei, Taiwan, 4 Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, 5 Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
aspirin, clopidogrel, stroke, intracranial hemorrhage, intravenous thrombolysis
Citation
Lin S-F, Hu H-H, Ho B-L, Chen C-H, Chan L, Lin H-J, Sun Y, Lin Y-Y, Chen P-L, Lin S-K, Wei C-Y, Lin Y-T, Lee J-T, Chao A-C and Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group (2021) Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience. Front. Neurol. 12:737437. doi: 10.3389/fneur.2021.737437
Received
07 July 2021
Accepted
08 July 2021
Published
17 September 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2021
Updates
Copyright
© 2021 Lin, Hu, Ho, Chen, Chan, Lin, Sun, Lin, Chen, Lin, Wei, Lin, Lee, Chao and Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: A-Ching Chao achch@cc.kmu.edu.twHan-Hwa Hu hanhwa@hotmail.com
This article was submitted to Stroke, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.